Ok Jun Lee | Cancer Biotechnology | Innovative Research Award

Published on by Biotechnology Scientist

Innovative Research Award

Ok Jun Lee
Researcher Ok Jun Lee
Affiliation Chungbuk National University College of Medicine
Country South Korea
Scopus ID 7103020256
Documents 133
Citations 5,487
h-index 32
Subject Area Cancer Biotechnology
Event Biotechnology Scientist Awards
ORCID 0000-0002-5350-8751

Ok Jun Lee
Chungbuk National University College of Medicine, South Korea.

Ok Jun Lee is a researcher affiliated with Chungbuk National University College of Medicine, South Korea, whose scholarly work has contributed to the advancement of cancer biotechnology, molecular oncology, and translational biomedical research. The recognition presented through the Innovative Research Award highlights sustained academic productivity, scientific influence, and contribution to biotechnology-focused research initiatives.[1]

Abstract

This article presents a scholarly overview of Ok Jun Lee and the academic accomplishments associated with the Innovative Research Award. The profile examines research productivity, publication output, citation influence, and contributions to cancer biotechnology. The assessment reflects recognized indicators of scientific achievement, including peer-reviewed publications, citation performance, and sustained engagement in biomedical innovation.[1][2]

Keywords

Cancer Biotechnology; Molecular Oncology; Translational Medicine; Biomedical Research; Cancer Biomarkers; Biotechnology Innovation; Precision Medicine; Scientific Impact; Academic Excellence; Research Recognition.

Introduction

Biotechnology continues to play a central role in advancing healthcare through the development of diagnostic tools, therapeutic approaches, and molecular-level understanding of disease mechanisms. Researchers working within cancer biotechnology contribute to the identification of biomarkers, signaling pathways, and translational strategies aimed at improving patient outcomes. Within this context, Ok Jun Lee’s publication record demonstrates active participation in scientific investigations that align with contemporary challenges in oncology and biomedical sciences.[2][3]

Research Profile

Ok Jun Lee is affiliated with Chungbuk National University College of Medicine and has established a substantial research portfolio reflected through 133 indexed scholarly documents. The researcher’s citation performance exceeds 5,400 citations, while an h-index of 32 indicates consistent scholarly influence across multiple publications. Such indicators are commonly used in academic evaluation frameworks to assess research visibility and impact within scientific communities.[1][4]

The principal subject area associated with this profile is cancer biotechnology, encompassing investigations related to cancer biology, molecular diagnostics, therapeutic targets, and translational research methodologies. The interdisciplinary nature of biotechnology allows findings from laboratory studies to support clinical and healthcare applications.[3]

Research Contributions

The research contributions associated with Ok Jun Lee encompass scientific studies addressing molecular mechanisms involved in cancer progression, cellular regulation, and biomarker discovery. Publications within cancer biotechnology frequently contribute to the broader understanding of disease pathogenesis and therapeutic development.[5]

Additional scholarly activities include participation in collaborative research networks, peer-reviewed publication efforts, and dissemination of scientific findings through recognized academic channels. Such contributions support knowledge exchange and encourage innovation across biotechnology-related disciplines.[2]

Publications

The publication portfolio attributed to the researcher includes peer-reviewed journal articles and collaborative scientific studies indexed within major academic databases. Research outputs demonstrate sustained engagement with biotechnology and cancer-focused investigations, contributing to cumulative scientific knowledge and citation growth over time.[1][5]

  • Peer-reviewed oncology and biotechnology publications.
  • Collaborative multidisciplinary research studies.
  • Scientific articles focusing on molecular and translational medicine.
  • Research outputs contributing to citation-based scholarly impact.

Research Impact

Research impact may be assessed through citation metrics, publication quality, collaborative engagement, and knowledge translation. With more than 5,487 citations generated across thousands of citing documents, the scholarly work associated with Ok Jun Lee demonstrates visibility within the international research community. Citation-based indicators suggest that published findings have informed subsequent investigations and contributed to ongoing scientific discourse.[1][4]

Award Suitability

The Innovative Research Award recognizes researchers whose academic records demonstrate measurable contributions to scientific advancement. Based on documented publication output, citation performance, and engagement within cancer biotechnology, Ok Jun Lee presents characteristics commonly associated with candidates for academic recognition programs. Evaluation criteria such as scholarly productivity, research quality, and scientific influence align with the objectives of biotechnology-focused award initiatives.[1]

Conclusion

Ok Jun Lee’s academic profile reflects sustained involvement in cancer biotechnology research through a substantial body of publications, strong citation performance, and interdisciplinary scientific contributions. The Innovative Research Award profile serves as a structured overview of scholarly achievements and highlights the continuing importance of biotechnology research in advancing biomedical knowledge and healthcare innovation.[1][3]

References

    1. Elsevier. (n.d.). Scopus Author Details: Ok Jun Lee, Author ID 7103020256. Scopus Database.
      https://www.scopus.com/authid/detail.uri?authorId=7103020256
    2. ORCID. (n.d.). ORCID Record for Ok Jun Lee.
      https://orcid.org/0000-0002-5350-8751
    3. National Cancer Institute. (n.d.). Cancer Research and Biotechnology Resources.
      https://www.cancer.gov/research
    4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    5. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of Cancer: The Next Generation.

Joanna Bojarska | Cancer Biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Assist. Prof. Dr. Joanna Bojarska | Cancer Biotechnology | Best Researcher Award

Chemistry Department at Technical University of Lodz | Poland

Assist. Prof. Dr. Joanna Bojarska is a dedicated researcher and academic at the Technical University of Lodz in Poland, where she works within the Department of Chemistry. Her expertise lies in supramolecular chemistry, particularly the study of short peptides and modified amino acids that hold immense promise in biomedical research. With a strong publication record and significant citation impact, she has established a reputation for advancing knowledge in structural and functional peptide chemistry. She is widely recognized for her contributions to understanding the therapeutic potential of cyclic and pseudocyclic peptide scaffolds, and her scientific career reflects an enduring commitment to both fundamental research and applied biomedical innovation.

Profile

Orcid | Scopus | Google scholar

Education

Assist. Prof. Dr. Joanna Bojarska has pursued a rigorous academic path that highlights her devotion to chemical and biomedical sciences. She has achieved advanced qualifications in the exact and natural sciences, supported by her extensive work on supramolecular chemistry of short peptides and modified amino acids. Her educational journey was further enriched by international training opportunities, including specialized biochemical studies that strengthened her interdisciplinary expertise. These experiences have not only shaped her technical competence but also positioned her as a global thinker capable of integrating diverse perspectives in research. Her academic achievements were later complemented by her progression into professorial roles, affirming her place as a recognized leader in her discipline.

Experience

Her professional career has been closely tied to the Technical University of Lodz, where she has contributed extensively to research and education. As a researcher, she has led and participated in numerous projects addressing innovative approaches to peptide-based supramolecular systems, drug and vaccine design, and the structural exploration of therapeutic scaffolds. She has successfully combined experimental investigations with computational modeling, producing comprehensive insights into the function and design of bioactive compounds. In addition to her research responsibilities, she has taken on roles in teaching and mentoring, ensuring that her expertise also benefits the academic growth of students and colleagues. Her involvement in European collaboration projects, particularly through academic mobility initiatives, further reflects her international engagement and commitment to cross-border scientific exchange.

Research Interest

The central theme of her research is supramolecular chemistry, with a specific interest in the structural and functional properties of short peptides. Assist. Prof. Dr. Joanna Bojarska has focused extensively on cyclic and pseudocyclic motifs, which are highly relevant in therapeutic applications, including anticancer and neuroprotective strategies. Her studies often bridge the gap between chemistry and medicine, emphasizing the potential of peptides in targeting G protein-coupled receptors and other pharmacological pathways. She applies both experimental crystallographic approaches and advanced computational techniques to investigate the stability, interactions, and biological activity of peptide scaffolds. Her work contributes to the smart design of ligands and theranostic agents, aligning scientific curiosity with clinical applicability.

Award

Throughout her career, she has been honored with multiple recognitions that highlight her impact as both a researcher and educator. She has received several Rector’s Awards for her achievements in scientific research, excellence in teaching, and popularization of science. Her contributions have also been acknowledged at the international level, with nominations for highly respected honors such as the Horizon Prizes for Education and the Protein and Peptide Science Award. Beyond awards, her research leadership is reflected in successful management of national and European grants, including projects aimed at developing innovative biomedically relevant peptide systems and sustainable solutions in food and health sciences. Her ability to translate research ideas into tangible results has also led to patent recognition for peptide-based supramolecular systems with therapeutic potential.

Publication Top Notes

A global review on short peptides: frontiers and perspectives.
Year: 2021
Citations: 389

Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold.
Year: 2021

Supramolecular synthon hierarchy in cyclopropyl-containing peptide-derived compounds.
Year: 2022

Structural and biofunctional insights into the cyclo(Pro-Pro-Phe-Phe-) scaffold from experimental and in silico studies: Melanoma and beyond.
Year: 2022

An experimental and computational investigation of the cyclopentene-containing peptide-derived compounds: focus on pseudocyclic motifs via intramolecular interactions.
Year: 2024

Short Peptides: Novel Supramolecular Synthons for Designing Anticancer Theranostics.
Year: 2023

Drug and vaccine design platform as an innovative research and teaching tool.
Year: 2022

Conclusion

In conclusion, Assist. Prof. Dr. Joanna Bojarska represents the profile of a modern scientist who skillfully balances research, teaching, and innovation. Her career reflects a seamless integration of supramolecular chemistry with biomedical applications, emphasizing the translational potential of short peptides as therapeutic agents. Through her extensive publications, funded projects, and international collaborations, she has contributed to advancing the structural understanding of bioactive compounds while also engaging in projects of societal and educational significance. Her scientific achievements, combined with her dedication to fostering academic growth, position her as a leading figure in the interdisciplinary space where chemistry meets medicine. Her continuing work promises to inspire new discoveries and broaden the scope of peptide research in addressing global health challenges.